Hyalex announces first patients’ treatment in knee cartilage system trials
The two clinical trials are conducted in US and Europe to evaluate safety and performance of the HYALEX Knee Cartilage System. Hyalex Orthopaedics has announced the successful treatment of the first patients in the first-in-human clinical trials with its HYALEX... Read More →
Genesis Growth Tech Files Proxy on MindMaze Deal
Genesis Growth Tech Acquisition filed a proxy and prospectus on its $21 million deal with MindMaze, a digital therapeutics firm. The sponsor is obligated to pay MindMaze the $21 million purchase price by May 31. The parties have also agreed... Read More →
Titan Medical progresses with Conavi merger
Titan Medical today provided a progress update regarding its planned merger with surgical guidance technology company Conavi Medical. The companies entered into a definitive amalgamation agreement to combine in an all-stock transaction last month. They aim to commercialize Conavi’s Novasight Hybrid system for guiding common... Read More →
Beating Heart Disease: How ConKay leads the charge against Valvular Regurgitation?
“Our purpose goes beyond technology. We’re driven by a profound commitment to changing lives.” – Albert Yuan, Founder, President and CEO – ConKay Medical Systems Imagine each morning, struggling for breath as if your lungs are tightly bound by chains.... Read More →
Seven start-ups to go head-to-head at Femtech World Awards
Seven femtech start-ups have made the shortlist for Femtech World’s OB/GYN Innovation award sponsored by Cross-Border Impact Ventures. Cross–Border Impact Ventures is on a mission to revolutionise venture capital investing in health technology. The company invests in early-growth stage health... Read More →
Raydiant Oximetry Secures FDA Approval for Lumerah Investigational Device Exemption (IDE) Study
SAN RAMON, Calif., April 10, 2024 (GLOBE NEWSWIRE) — Raydiant Oximetry, Inc., a clinical-stage medical device company that develops medical technologies to improve outcomes for mothers and babies during childbirth, announces that the United States Food and Drug Administration (FDA)... Read More →
Liberate Medical Announces PREVENT Study with $6.5M Grant Funding from the US DoD – Enrolls First Patients Globally
The PREVENT study is the pivotal clinical trial of the VentFree® Respiratory Muscle Stimulator and will support FDA regulatory clearance of VentFree CRESTWOOD, KY 9 April 2024 – Liberate Medical is proud to announce the successful commencement of patient enrollment... Read More →
Neurotech startup Neurovalens gets FDA clearance for noninvasive anxiety treatment
A 2019 rule change by the U.S. medical devices regulator aimed at encouraging innovations targeting insomnia and anxiety is bearing fruit: Neurovalens, a Belfast-based startup that for over a decade has been developing technology to deliver noninvasive electrical stimulation of the... Read More →
Onkos Surgical Announces First FDA De Novo Approval of an Antibacterial Coating for Tumor and Revision Orthopaedic Implants
Bacterial contamination of orthopaedic implants is a growing clinical challenge that burdens the healthcare system and can lead to dangerous, potentially fatal complications for patients. PARSIPPANY, N.J., April 8, 2024 /PRNewswire/ — Onkos Surgical, an orthopaedic company founded to address... Read More →
Titan Medical Merges with Conavi Medical
Titan Medical Inc. (“Titan”) announced on March 18, 2024, that it is merging with Conavi Medical Inc. (“Conavi”). Titan is a medical technology licensing company based in Toronto with an extensive patent portfolio focusing on robotic assisted surgery. Conavi is a medical device company specializing in... Read More →